StockData
Kailera Therapeutics, Inc. logo

Kailera Therapeutics, Inc. (KLRA) stock

KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$12.20−0.37 (-2.94%)

Close on Nov 17, 2026Market cap $1.58BP/E –Yield –

Kailera Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Kailera Therapeutics's total assets was $1.08B at Sep 30, 2026. For fiscal 2025 it was $692.29M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$692.29M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.08B–
Q2 FY2026Jun 30, 2026$1.21B–
Q1 FY2026Mar 31, 2026$624.76M–
Q4 FY2025Dec 31, 2025$692.29M–

More Kailera Therapeutics figures

See a number that looks wrong?